Sharon, MA, United States of America

Murray B Resnick


Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Murray B Resnick

Introduction

Murray B Resnick is a notable inventor based in Sharon, MA (US). He has made significant contributions to the field of medical diagnostics and treatment, holding 2 patents that reflect his innovative approach to healthcare challenges.

Latest Patents

One of his latest patents is titled "Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis." This patent describes a method for diagnosing eosinophilic esophagitis by studying the levels of expression of novel markers, including ALOX15 or metabolites thereof, TNFAIP6, FLG, SLURP1, or CRISP3. Additionally, it outlines methods for treating eosinophilic esophagitis. Another significant patent is "Collagens as markers for breast cancer treatment." This specification provides methods for determining whether a subject suffering from ER+/HER2+ breast cancer is likely to respond to adjuvant and neoadjuvant chemotherapy, along with methods for treating such subjects.

Career Highlights

Murray has worked with reputable institutions, including Rhode Island Hospital, which is a partner of Lifespan. His work in these environments has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Throughout his career, Murray has collaborated with esteemed colleagues such as Andres Matoso and Vincent A Mukkada. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.

Conclusion

Murray B Resnick's contributions to medical diagnostics and treatment exemplify the impact of innovation in healthcare. His patents not only address critical health issues but also pave the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…